These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 38592263)

  • 41. Uremic Toxins and Cardiovascular Risk in Chronic Kidney Disease: What Have We Learned Recently beyond the Past Findings?
    El Chamieh C; Liabeuf S; Massy Z
    Toxins (Basel); 2022 Apr; 14(4):. PubMed ID: 35448889
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association between Protein-Bound Uremic Toxins and Asymptomatic Cardiac Dysfunction in Patients with Chronic Kidney Disease.
    Chinnappa S; Tu YK; Yeh YC; Glorieux G; Vanholder R; Mooney A
    Toxins (Basel); 2018 Dec; 10(12):. PubMed ID: 30563136
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reduction of protein-bound uraemic toxins in plasma of chronic renal failure patients: A systematic review.
    Saar-Kovrov V; Zidek W; Orth-Alampour S; Fliser D; Jankowski V; Biessen EAL; Jankowski J
    J Intern Med; 2021 Sep; 290(3):499-526. PubMed ID: 33792983
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Animal Models for Studying Protein-Bound Uremic Toxin Removal-A Systematic Review.
    Ahmed S; de Vries JC; Lu J; Stuart MHV; Mihăilă SM; Vernooij RWM; Masereeuw R; Gerritsen KGF
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686004
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Medium cut-off dialyzer for middle molecular uremic toxins in AKI and chronic dialysis.
    Fiorentino M; La Fergola F; De Rosa S
    J Nephrol; 2024 Jan; 37(1):23-37. PubMed ID: 37843731
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gut Microbiota and Their Derived Metabolites, a Search for Potential Targets to Limit Accumulation of Protein-Bound Uremic Toxins in Chronic Kidney Disease.
    Steenbeke M; Valkenburg S; Gryp T; Van Biesen W; Delanghe JR; Speeckaert MM; Glorieux G
    Toxins (Basel); 2021 Nov; 13(11):. PubMed ID: 34822593
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increasing the removal of protein-bound uremic toxins by liposome-supported hemodialysis.
    Shi Y; Wang Y; Ma S; Liu T; Tian H; Zhu Q; Wang W; Li Y; Ding F
    Artif Organs; 2019 May; 43(5):490-503. PubMed ID: 30375673
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A novel mathematical model of protein-bound uremic toxin kinetics during hemodialysis.
    Maheshwari V; Thijssen S; Tao X; Fuertinger D; Kappel F; Kotanko P
    Sci Rep; 2017 Sep; 7(1):10371. PubMed ID: 28871178
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Medium Cut-Off Membrane Does Not Lower Protein-Bound Uremic Toxins.
    Kim YG; Lee SH; Jung SW; Jung GT; Lim HJ; Kim KP; Jo YI; Jin K; Moon JY
    Toxins (Basel); 2022 Nov; 14(11):. PubMed ID: 36356029
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Uremic Toxins: how can we improve the removal today?].
    Teatini U; Romei Longhena G
    G Ital Nefrol; 2017 Sep; 34(5):89-101. PubMed ID: 28963830
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Removal of protein-bound, hydrophobic uremic toxins by a combined fractionated plasma separation and adsorption technique.
    Brettschneider F; Tölle M; von der Giet M; Passlick-Deetjen J; Steppan S; Peter M; Jankowski V; Krause A; Kühne S; Zidek W; Jankowski J
    Artif Organs; 2013 Apr; 37(4):409-16. PubMed ID: 23330821
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In silico comparison of protein-bound uremic toxin removal by hemodialysis, hemodiafiltration, membrane adsorption, and binding competition.
    Maheshwari V; Thijssen S; Tao X; Fuertinger DH; Kappel F; Kotanko P
    Sci Rep; 2019 Jan; 9(1):909. PubMed ID: 30696874
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Generation, clearance, toxicity, and monitoring possibilities of unaccounted uremic toxins for improved dialysis prescriptions.
    Atherton JG; Hains DS; Bissler J; Pendley BD; Lindner E
    Am J Physiol Renal Physiol; 2018 Oct; 315(4):F890-F902. PubMed ID: 29537310
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cardiotoxicity of Uremic Toxins: A Driver of Cardiorenal Syndrome.
    Lekawanvijit S
    Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30200452
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gut microbiota generation of protein-bound uremic toxins and related metabolites is not altered at different stages of chronic kidney disease.
    Gryp T; De Paepe K; Vanholder R; Kerckhof FM; Van Biesen W; Van de Wiele T; Verbeke F; Speeckaert M; Joossens M; Couttenye MM; Vaneechoutte M; Glorieux G
    Kidney Int; 2020 Jun; 97(6):1230-1242. PubMed ID: 32317112
    [TBL] [Abstract][Full Text] [Related]  

  • 56. AST-120 to Target Protein-Bound Uremic Toxins Improves Cardiac Output and Kidney Oxygenation in Experimental Chronic Kidney Disease.
    Sivertsson E; Ceder S; Nangaku M; Hansell P; Nordquist L; Palm F
    Kidney Blood Press Res; 2023; 48(1):114-123. PubMed ID: 36791683
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gut Microbiota and Cardiovascular Uremic Toxicities.
    Velasquez MT; Centron P; Barrows I; Dwivedi R; Raj DS
    Toxins (Basel); 2018 Jul; 10(7):. PubMed ID: 29997362
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Uremic Toxin Clearance and Cardiovascular Toxicities.
    Mair RD; Sirich TL; Meyer TW
    Toxins (Basel); 2018 Jun; 10(6):. PubMed ID: 29865226
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Uremic Toxins and Frailty in Patients with Chronic Kidney Disease: A Molecular Insight.
    Chao CT; Lin SH
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34200937
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Elucidating the Molecular Interactions between Uremic Toxins and the Sudlow II Binding Site of Human Serum Albumin.
    Smith J; Pfaendtner J
    J Phys Chem B; 2020 May; 124(19):3922-3930. PubMed ID: 32338898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.